On December 5, 2025, the Bank of Russia announced the partial removal of previously established limits on foreign currency transfers abroad for Russian citizens and individuals who are non-residents from friendly countries. The relaxations came into effect on December 8, 2025.

In June 2024, the pharmaceutical industry faced a new practice by the Federal Antimonopoly Service (FAS), which began to consistently recognize the introduction of generic drugs onto the market as unfair competition.

On 17 November 2025, the Russian Ministry of Health published the Order No. 669n (hereinafter - the "Order") approving the procedure for healthcare professionals to prescribe dietary supplements when providing medical care to citizens.

On October 24, 2025, the Government of the Russian Federation submitted to the State Duma of the Russian Federation Draft Law No. 1050649-8 " On Amendments to the Federal Law "On Investment Partnerships "(hereinafter - the "IP Law") and Fundamentals of Legislation of the Russian Federation on Notaries" (hereinafter - the "Bill").

Stricter score criteria for EV chargers and converters begin in 2026, followed by new rules for Russian bearings in machine tools from July 2026.

The Digital Personal Data Protection Rules, 2025 (“DPDP Rules”), have now been notified and the same has been passed qua the Digital Personal Data Protection Act (DPDP Act), 2023.

Currently, the efforts of state authorities in the fields of pharmaceuticals and healthcare are also aimed at implementing the Strategy for the Development of the Pharmaceutical Industry of the Russian Federation for the Period up to 2030 (hereinafter referred to as the “Pharma 2030 Strategy”). One of the goals of the Pharma 2030 Strategy is to increase the share of domestically produced medicinal products in the total consumption volume from 61.8% to 66.6% by 2030. In this regard, measures to support Russian medicinal products manufacturers continue to be implemented.

On August 7, 2025, a draft law “On Amending the Federal Law ‘On Protection of Competition’” (hereinafter, the “Draft Law”) was published. Prepared by the Federal Antimonopoly Service (hereinafter, the “FAS”), it aims to significantly narrow the scope of antitrust immunities concerning the results of intellectual activity.

On 1 September 2025, a draft resolution of the Government of the Russian Federation “On approving the procedure and criteria for compiling a list of strategically significant medicines” (“Draft Resolution”) was submitted for public discussion.

On August 11, 2025, amendments to the Labor Code of the Russian Federation (hereinafter referred to as the "LC of the RF") entered into force. These amendments concern the provision of guarantees to part-time employees upon termination of an employment contract with them at their primary place of work due to the liquidation of the organization or redundancy or staff cuts at the organization.